US Patent 8193211 Controlled release compositions of gamma-hydroxybutyrate
Patent 8193211 was granted and assigned to Supernus Pharmaceuticals, Inc. on June, 2012 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8193211 Controlled release compositions of gamma-hydroxybutyrate
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
